Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Boric acid is an inorganic compound with the formula H₃BO₃, commonly used as an antiseptic, insecticide, flame retardant, and industrial chemical. In medicine, it is primarily utilized for its mild antifungal and antibacterial properties. Boric acid inhibits biofilm formation and hyphal transformation in Candida albicans, which are critical for fungal virulence. It is also used in ophthalmic preparations as a preservative and buffer due to its antimicrobial activity[3][5]. Its mechanism of action involves disrupting microbial cell processes at high concentrations over prolonged exposure[3]. Boric acid is well absorbed from the gastrointestinal tract but poorly through intact skin; it is excreted mainly unchanged via the kidneys[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on boric acid.